Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial is a research paper published in The Journal of Infectious Diseases (2023). On theSindex it has a DataRank of 0.270. It has been cited 3 times, with 1 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0.0620
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 1 citer.
National Institutes of Health
Grant: UM1AI068636
National Institutes of Health
Grant: UM1AI068634
National Institutes of Health
Grant: UM1AI106701
NIAID NIH HHS
Grant: UM1 AI069423
NIAID NIH HHS
Grant: UM1 AI069424
NIAID NIH HHS
Grant: U01 AI068636
NIAID NIH HHS
Grant: U01 AI069424
NIAID NIH HHS
Grant: UM1 AI069463
NIAID NIH HHS
Grant: U01 AI069463
NIAID NIH HHS
Grant: UM1 AI069432
National Institute of Allergy and Infectious Diseases
FWCI
0.47
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals